Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 4, 2004
View Archived Issues
Complementary effects of rosiglitazone and metformin in type 2 diabetes
Read More
Johnson & Johnson to acquire Merck's stake in European nonRx joint venture
Read More
New round of financing at Igeneon to advance lead candidates
Read More
Nautilus develops enhanced IFNbeta molecules for multiple sclerosis
Read More
New data support benefit of Namenda for Alzheimer's
Read More
Results from two HspE7 trials
Read More
Positive phase I/II results for NicVAX
Read More
Regeneron to test IL-1 Trap in phase IIb study
Read More
NOP World Heath report on Symbyax
Read More
Cell Therapeutics strengthens late-stage development product pipeline
Read More
Antisoma continues to acquire new products and advance existing programs
Read More
Solifenacin reported both safe and effective in overactive bladder
Read More
MDM2 directly suppresses p21: broader anticancer activity for antisense MDM2 inhibitors
Read More
Orchid scientists develop new COX inhibitors
Read More
Novel 5-HT2A receptor antagonists and their use covered by Biovitrum patent
Read More
Janssen researchers present NADPH oxidase inhibitors for arthritis and AD
Read More
Aventis describes three novel series of NHE-1 inhibitors
Read More
New protein kinase inhibitors for cancer and other disorders discovered at Janssen
Read More
New 5-HT6 receptor ligands prepared and tested at Wyeth
Read More
Targacept claims new nAChR modulators with utility in pain and CNS disorders
Read More
New PDE4 inhibitors with utility in cognition disorders identified at Memory Pharmaceuticals
Read More
Lilly to advance LY-519818 into registrational studies
Read More
Endpoint met in phase IIa study of DMI-7958
Read More
Compugen discovers novel soluble CD40 protein
Read More
Myfortic receives FDA approval
Read More
ARH-460-16-2 set to enter clinic early next year
Read More
Abbott and Millennium identify melanocortin receptor antagonist for disease-associated weight loss
Read More
H3 Pharma submits Sanvar IR NDA
Read More
Novel CDK inhibitor with in vitro antiapoptotic activity described
Read More
Strathclyde Institute for Drug Research seeks support for development of restenosis treatment
Read More
Novel anticonvulsant, YM-928, effective in generalized seizure models
Read More
Protective effects of brain-derived neurotrophic factor enhanced with RS-0466
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe